Nearly 9 in 10 children given intravenous (IV) magnesium for refractory asthma ended up being admitted to the hospital, but new research suggests that may be partly due to a lack of clarity about the ...

Inadvertent administration of tranexamic acid instead of magnesium sulfate poses risks for thromboembolic complications and untreated seizures. A product mix-up has prompted Amneal to voluntarily ...

Intravenous magnesium sulfate before preterm birth at 30 to 34 weeks of gestation does not improve child survival free of cerebral palsy, according to a study published in the Aug. 15 issue of the ...

Please provide your email address to receive an email when new articles are posted on . IV magnesium therapy administered after initial asthma treatment in the ED was associated with subsequent ...

Please provide your email address to receive an email when new articles are posted on . IV magnesium for children with moderate-to-severe asthma exacerbations was associated with increased ...

Intravenous (IV) administration of magnesium sulphate was associated with a reduced risk for in-hospital mortality and 30-day all-cause ICU mortality but possibly extended ICU and hospital stays among ...

Magnesium sulfate does not delay delivery when used in patients with preterm labor. Although magnesium sulfate is not associated with any serious adverse maternal outcomes, it may be associated with ...